Abstract
There have been significant changes in drug regulation in many countries over the last five years. The Medicines Control Agency (MCA) believes it has been in the forefront of these changes and it is committed to improving its performance further. This improvement in both efficiency and effectiveness should benefit both the pharmaceutical industry and patients.
Get full access to this article
View all access options for this article.